Creative Medical Technology Holdings (NASDAQ: CELZ) announced that all patients have been enrolled and treated across its FDA-cleared ADAPT clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE